Article Link: FDA Approves Admelog (insulin lispro) Rapid-Acting “Follow-On” Insulin Product to Treat Diabetes December 11, 2...
Novo Nordisk Receives FDA Approval of Ozempic (semaglutide) Injection For the Treatment of Adults with Type 2 Diabetes
Article Link: Novo Nordisk Receives FDA Approval of Ozempic (semaglutide) Injection For the Treatment of Adults with Type 2 Diabetes Dece...
Sunovion Receives FDA Approval for Lonhala Magnair (glycopyrrolate) Inhalation Solution to Treat COPD
Article Link: Sunovion Receives FDA Approval for Lonhala Magnair (glycopyrrolate) Inhalation Solution to Treat COPD MARLBOROUGH, Mass....
FDA Approves Ogivri (trastuzumab-dkst), a Biosimilar to Herceptin
Article Link: FDA Approves Ogivri (trastuzumab-dkst), a Biosimilar to Herceptin December 1, 2017 — The U.S. Food and Drug Administr...
FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder
Article Link: FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder November 30, 2017 — The U.S. Fo...
FDA Approves Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep
Article Link: FDA Approves Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Pa...
FDA Approves Juluca (dolutegravir and rilpivirine) for the Maintenance Treatment of Virologically Suppressed HIV-1 Infection
Article Link: FDA Approves Juluca (dolutegravir and rilpivirine) for the Maintenance Treatment of Virologically Suppressed HIV-1 Infection ...
FDA Approves Kaléo’s Auvi-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Article Link: FDA Approves Kaléo’s Auvi-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Sma...
FDA Approves Sutent (sunitinib malate) for Adjuvant Treatment of Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
Article Link: FDA Approves Sutent (sunitinib malate) for Adjuvant Treatment of Adult Patients at High Risk of Recurrent Renal Cell Carcinoma �...
FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
Article Link: FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors Source: FDA New Drug Approvals
